Acute Pancreatitis Clinical Trial
Official title:
An Observational Study of the Role of Intra-abdominal Pressure Monitoring in Patients With Acute Pancreatitis
Acute pancreatitis is a multi-system disease with an unpredictable clinical course and
significant morbidity and mortality Approximately 20% of patients develop multi-organ
failure requiring management within a critical care environment However much of the
pathophysiology of the disease, particularly understanding why some patients develop
life-threatening disease whilst others have a relatively benign course, remains unclear.
It well recognised that intra-abdominal hypertension (IAH) is a cause for organ dysfunction
in critically ill patients and is associated with higher morbidity and mortality rates
(Sugrue et al., 1999). Abdominal compartment syndrome (defined as an increase in
intra-abdominal pressure (IAP) >20mmHg) is associated with new organ failure (Malbrain et
al., 2006). The mechanisms believed to contribute to IAH in acute pancreatitis include
increased capillary permeability, hypoalbuminaemia and volume overload ("third space
losses"), producing retroperitoneal and visceral oedema (Dambrauskas et al., 2009).
Several small studies have recently described the link between intra-abdominal hypertension
and adverse outcome in acute pancreatitis ( Dambrauskas et al., 2009; de Waele et al.,
2005), however none of the authors appreciate the potential predictive value of there
conclusions or the potential as a target for therapeutic intervention to alter the disease
course.
This study aims to study the natural history of intra-abdominal pressures in acute
pancreatitis and determine whether they truly do have a predictive value or whether they are
simply another marker of organ failure in a multi-system disease with notoriously poor
outcome.
Acute pancreatitis is a multi-system disease with an unpredictable clinical course and
significant morbidity and mortality (Wilmer, 2004). Approximately 20% of patients develop
multi-organ failure requiring management within a critical care environment (Dambrauskas et
al., 2009). However much of the pathophysiology of the disease, particularly understanding
why some patients develop life-threatening disease whilst others have a relatively benign
course, remains unclear.
Many predictive scales have resulted from attempts to predict which patients are likely to
develop severe disease (Imrie, Ranson, APACHE-II etc.) (Barreto & Rodriguez, 2007). However
none of these scoring systems actually correlate clinical findings with the pathophysiology
of the disease process, making comprehension of the rationale for the prognostic value which
these scales have been shown to have difficult. This has lead latterly to interest in
measurement of intra-abdominal pressures (IAP) as a potential novel method to predict
outcome in acute pancreatitis (Buter et al., 2002) since intra-abdominal hypertension can be
explained by the disease processes in acute pancreatitis.
It well recognised that intra-abdominal hypertension (IAH) is a cause for organ dysfunction
in critically ill patients and is associated with higher morbidity and mortality rates
(Sugrue et al., 1999). Abdominal compartment syndrome (defined as an increase in IAP
>20mmHg) is associated with new organ failure (Malbrain et al., 2006). The mechanisms
believed to contribute to IAH in acute pancreatitis include increased capillary
permeability, hypoalbuminaemia and volume overload ("third space losses"), producing
retroperitoneal and visceral oedema (Dambrauskas et al., 2009).
Several small studies have recently described the link between intra-abdominal hypertension
and adverse outcome in acute pancreatitis ( Dambrauskas et al., 2009; de Waele et al.,
2005), however none of the authors appreciate the potential predictive value of there
conclusions or the potential as a target for therapeutic intervention to alter the disease
course.
This study aims to study the natural history of intra-abdominal pressures in acute
pancreatitis and determine whether they truly do have a predictive value or whether they are
simply another marker of organ failure in a multi-system disease with notoriously poor
outcome.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05410795 -
Establishment and Verification of Pancreatic Volume Formula Based on Imaging
|
||
Recruiting |
NCT04195347 -
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
|
Phase 1/Phase 2 | |
Completed |
NCT04735055 -
Artificial Intelligence Prediction for the Severity of Acute Pancreatitis
|
||
Completed |
NCT02928718 -
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations
|
||
Terminated |
NCT02885441 -
Treatment of Acute Pancreatitis With Ketorolac
|
Phase 4 | |
Completed |
NCT02563080 -
Pancreatic Exocrine Insufficiency in Acute Pancreatitis
|
||
Recruiting |
NCT01626911 -
Continuous Regional Arterial Infusion of Low Molecular Weight Heparin in Patients With Severe Acute Pancreatitis
|
N/A | |
Completed |
NCT01507766 -
The Correlations Between Early Enteral Nutrition and Intra-abdominal Pressure in Severe Acute Pancreatitis
|
Phase 4 | |
Completed |
NCT04901949 -
The Course of Acute Pancreatitis in Patients With Different BMI Groups
|
||
Recruiting |
NCT04814693 -
Conventional Endoscopic Techniques Versus EndoRotor® System for Necrosectomy of Walled of Necrosis
|
N/A | |
Completed |
NCT02743364 -
Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis
|
Phase 2 | |
Recruiting |
NCT05281458 -
Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections
|
N/A | |
Not yet recruiting |
NCT04990336 -
Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis
|
N/A | |
Not yet recruiting |
NCT03259880 -
Searching the Best Prognostic Factor in Out Come Evaluation in Patients With Acute Pancreatitis Admitted at Assiut University Hospitals
|
N/A | |
Completed |
NCT02543658 -
Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension
|
Phase 2 | |
Recruiting |
NCT06023771 -
Invasive Intervention of Local Complications of Acute Pancreatitis
|
||
Not yet recruiting |
NCT05501314 -
Remote Home Monitoring Acute Pancreatitis
|
N/A | |
Completed |
NCT02897206 -
Imipenem Prophylaxis in Patients With Acute Pancreatitis
|
Phase 4 | |
Recruiting |
NCT03634787 -
Heat Shock Proteins: a Pathogenic Driver and Potential Therapeutic Target in Acute Pancreatitis
|
||
Active, not recruiting |
NCT04989166 -
Effect of Nano-curcumin Supplementation in Acute Pancreatitis
|
N/A |